Pfizer Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $37.31B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $2.31B | 6.2% |
| Business Acquisitions | $16.39B | 43.9% |
| Stock Repurchases | $2.00B | 5.4% |
| Other Financing | $8.57B | 23.0% |
| Working Capital | $8.04B | 21.6% |
| Net Cash Flow | $0 | 0.0% |